SLC2A1 and cancer: GLUT1 expression is raised in various malignant tumor cells, including liver, pancreas, breast, esophagus, lung, brain, kidney, skin, ovary, colon, endometrial, and cervical malignant tumors, and the positive expression rate reached 50%.